Diabetes and COVID-19

Area of Science:

• Internal Medicine
• Infectious Diseases
• Endocrinology

Background:

• Coronavirus disease-19 (COVID-19) presents increased mortality risks associated with several comorbidities.
• Hyperglycemia and diabetes mellitus are significant risk factors, leading to severe COVID-19 complications, higher ICU admission rates, and increased mortality.

Purpose of the Study:

• To investigate the impact of hyperglycemia and diabetes on COVID-19 severity and mortality.
• To highlight the mechanisms by which elevated blood sugar levels exacerbate viral infections.
• To emphasize the need for integrated care strategies for diabetic patients with COVID-19.

Main Methods:

• Literature review and analysis of existing studies on COVID-19 and diabetes.
• Examination of clinical data linking hyperglycemia to COVID-19 outcomes.
• Analysis of immunological and molecular mechanisms affected by high blood glucose.

Main Results:

• Patients with diabetes or hyperglycemia exhibit a two- to four-fold increase in COVID-19 mortality and severity.
• Hyperglycemia impairs immune response, affecting bacterial degradation, neutrophil function, and viral clearance.
• Glycosylation induced by high blood sugar levels increases cellular susceptibility to viral inflammation and damage.

Conclusions:

• Effective management of COVID-19 in diabetic patients requires a multidisciplinary team approach.
• Proactive strategies focusing on comorbidities are essential to reduce complications and mortality.
• Integrated care can alleviate the burden on healthcare systems by improving patient outcomes.